BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34806769)

  • 1. Implantable cardioverter-defibrillators with end stage renal disease: Nationwide inpatient sample database results.
    Ayoub K; Fry E; Marji M; Masri A; Hesselson A; Ellison K
    Pacing Clin Electrophysiol; 2022 Jan; 45(1):124-131. PubMed ID: 34806769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and in-hospital outcome of patients with end-stage renal disease on dialysis referred for implantable cardioverter-defibrillator implantation.
    Aggarwal A; Wang Y; Rumsfeld JS; Curtis JP; Heidenreich PA;
    Heart Rhythm; 2009 Nov; 6(11):1565-71. PubMed ID: 19879533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher perioperative morbidity and in-hospital mortality in patients with end-stage renal disease undergoing nephrectomy for non-metastatic kidney cancer: a population-based analysis.
    Schmitges J; Trinh QD; Sun M; Hansen J; Bianchi M; Jeldres C; Perrotte P; Dahlem R; Shariat SF; Chun FK; Montorsi F; Menon M; Fisch M; Graefen M; Karakiewicz PI
    BJU Int; 2012 Sep; 110(6 Pt B):E183-90. PubMed ID: 22321256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A contemporary evaluation of carotid endarterectomy outcomes in patients with chronic kidney disease in the United States.
    Patel AR; Dombrovskiy VY; Vogel TR
    Vascular; 2017 Oct; 25(5):459-465. PubMed ID: 28181855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. End-stage renal disease is associated with increased post endoscopic retrograde cholangiopancreatography adverse events in hospitalized patients.
    Sawas T; Bazerbachi F; Haffar S; Cho WK; Levy MJ; Martin JA; Petersen BT; Topazian MD; Chandrasekhara V; Abu Dayyeh BK
    World J Gastroenterol; 2018 Nov; 24(41):4691-4697. PubMed ID: 30416316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and risk factors of colonoscopic post-polypectomy bleeding and perforation in patients with end-stage renal disease.
    Yang SC; Wu CK; Tai WC; Liang CM; Li YC; Yeh WS; Lee CH; Yang YH; Tsai TH; Hsu CN; Chuah SK
    J Gastroenterol Hepatol; 2020 Oct; 35(10):1704-1711. PubMed ID: 31900958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients with end-stage renal disease have poor outcomes after endovascular abdominal aortic aneurysm repair.
    Komshian S; Farber A; Patel VI; Goodney PP; Schermerhorn ML; Blazick EA; Jones DW; Rybin D; Doros G; Siracuse JJ
    J Vasc Surg; 2019 Feb; 69(2):405-413. PubMed ID: 29945838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative Morbidity and Mortality After Elective Anterior Cervical Fusion in Patients with Chronic and End-Stage Renal Disease.
    De la Garza Ramos R; Jain A; Nakhla J; Nasser R; Puvanesarajah V; Hassanzadeh H; Yassari R; Sciubba DM
    World Neurosurg; 2016 Nov; 95():480-485. PubMed ID: 27373417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Procedural outcomes and long-term survival following trans-venous defibrillator lead extraction in patients with end-stage renal disease.
    Shah AD; Peddareddy LP; Addish MA; Kelly K; Patel AU; Casey M; Goyal A; Leon AR; El-Chami MF; Merchant FM
    Europace; 2017 Dec; 19(12):1994-2000. PubMed ID: 28065887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in Use and In-Hospital Outcomes of Subcutaneous Implantable Cardioverter Defibrillators in Patients Undergoing Long-Term Dialysis.
    Pun PH; Parzynski CS; Friedman DJ; Sanders G; Curtis JP; Al-Khatib SM
    Clin J Am Soc Nephrol; 2020 Nov; 15(11):1622-1630. PubMed ID: 32967922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of chronic renal insufficiency with in-hospital outcomes after percutaneous coronary intervention.
    Gupta T; Paul N; Kolte D; Harikrishnan P; Khera S; Aronow WS; Mujib M; Palaniswamy C; Sule S; Jain D; Ahmed A; Cooper HA; Frishman WH; Bhatt DL; Fonarow GC; Panza JA
    J Am Heart Assoc; 2015 Jun; 4(6):e002069. PubMed ID: 26080814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal Trends and Outcomes of Implantable Cardioverter Defibrillators in Heart Failure and Chronic Kidney Disease in the United States.
    Talha KM; Jain V; Yamani N; Fatima K; Rashid AM; Hernandez GA; Dani SS; Fudim M; Minhas AMK
    Curr Probl Cardiol; 2023 Apr; 48(4):101548. PubMed ID: 36566952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-Hospital Mortality in Cirrhotic Patients with End-Stage Renal Disease Treated with Hemodialysis Versus Peritoneal Dialysis: A Nationwide Study.
    Nader MA; Aguilar R; Sharma P; Krishnamoorthy P; Serban D; Gordon-Cappitelli J; Shen W; Nilubol C; Li P; Lipkowitz M
    Perit Dial Int; 2017; 37(4):464-471. PubMed ID: 28348101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Panniculectomy Outcomes in Patients with End-Stage Renal Disease in Preparation for Renal Transplant.
    Mundra LS; Rubio GA; AlQattan HT; Thaller SR
    Aesthetic Plast Surg; 2018 Jun; 42(3):633-638. PubMed ID: 29270695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peri-Operative Outcomes Associated With the Placement of Implantable Cardioverter-Defibrillators in Patients With Sarcoidosis: A Nationwide Database Analysis.
    Singireddy S; Edusa S
    Cureus; 2024 Mar; 16(3):e55589. PubMed ID: 38576645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of Subcutaneous Implantable Cardioverter Defibrillator Implantation in Patients with End-Stage Renal Disease on Dialysis.
    El-Chami MF; Levy M; Kelli HM; Casey M; Hoskins MH; Goyal A; Langberg JJ; Patel A; Delurgio D; Lloyd MS; Leon AR; Merchant FM
    J Cardiovasc Electrophysiol; 2015 Aug; 26(8):900-904. PubMed ID: 25952566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. End-stage renal disease and lower gastrointestinal bleeding-A propensity-matched analysis of nationwide inpatient sample.
    Garlapati P; Gajjar B; Then EO; Gayam V
    Int J Clin Pract; 2021 Feb; 75(2):e13633. PubMed ID: 32741101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Advancing Age and Multiple Chronic Conditions on Mortality in Patients with End-Stage Renal Disease after Implantable Cardioverter-Defibrillator Placement.
    Krishnaswami A; Kiley ML; Anthony FF; Chen Y; Chen J; Rajagopal S; Liu TI; Young C; Paxton EW
    Perm J; 2016; 20(1):27-32. PubMed ID: 26562307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary prevention implantable cardioverter defibrillators in end-stage kidney disease patients on dialysis: a matched cohort study.
    Pun PH; Hellkamp AS; Sanders GD; Middleton JP; Hammill SC; Al-Khalidi HR; Curtis LH; Fonarow GC; Al-Khatib SM
    Nephrol Dial Transplant; 2015 May; 30(5):829-35. PubMed ID: 25404241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality, Length of Stay, and Cost Implications of Procedural Bleeding After Percutaneous Interventions Using Large-Bore Catheters.
    Redfors B; Watson BM; McAndrew T; Palisaitis E; Francese DP; Razavi M; Safirstein J; Mehran R; Kirtane AJ; Généreux P
    JAMA Cardiol; 2017 Jul; 2(7):798-802. PubMed ID: 28315573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.